Clinical Trial Update: BNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on BNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS) shows the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiorenal Syndrome
• Heart Failure
• Renal Insufficiency

Drugs mentioned

• BNP (B-type natriuretic peptide) (B-type natriuretic peptide)

Snippet

Sponsor: Stanford University | Conditions: Congestive Heart Failure Exacerbation, Renal Insufficiency | Phase 4 | Status: COMPLETED